Signios Bio Xenium 5K Spatial Transcriptomics Grant Program
Signios Bio is pleased to announce a new grant program leveraging the power of 10x Genomics Xenium 5K Spatial Transcriptomics
Signios Biosciences (“Signios Bio”), a science-first biotechnology company offering multiomics services, in collaboration with 10x Genomics, is offering a Signios-sponsored grant for the Xenium 5K Spatial Transcriptomics platform. This high-plex, imaging-based spatial technology enables targeted, single-cell-resolution gene expression profiling directly in human and mouse tissue sections.
The Xenium 5K Panel enables the simultaneous detection of up to 5,000 RNA targets per sample while preserving spatial context, allowing researchers to study cell-type localization, cell–cell interactions, biomarker expression, and pathway activity within intact tissue architecture. The platform supports FFPE and fresh-frozen tissues and delivers high-resolution gene expression maps at scale.
Signios Bio and 10x Genomics will work closely with the awardees to support experimental execution, data analysis, and publication efforts. Following completion of the study, award recipients will have the opportunity to present their findings at upcoming Signios/10x Genomics scientific events.
Grant Opportunity: What We’re Offering
We aim to support innovative spatial transcriptomics projects by awarding grants to top proposals using the Xenium 5K platform. The grant will cover the cost of Xenium processing and analysis for two Xenium 5K slides, with full access to Signios Bio’s expertise in workflow support, data generation, and analysis.
Awards:
A total of six awards will be granted across three categories:
- First Place Grant Recipient (1 grant winner):
- Priority access to a Xenium 5K run in our lab in Foster City, CA
- Full-service spatial transcriptomics, including sectioning, sample placement on two Xenium 5K slides, imaging, and data processing
- Support for data analysis and quality control by our bioinformatics team
- Second Place (2 grant winners):
- 50% off ($30k value) – total service cost $15K
- Xenium 5K run, two slides, in our lab in Foster City, CA
- Full-service spatial transcriptomics, including sectioning, sample placement on two Xenium 5K slides, imaging, and data processing
- Support for data analysis and quality control via our bioinformatics team
- Third Place (3 grant winners):
- 30% off ($30k value) – total service cost $21k
- Xenium 5K run, two slides, in our lab in Foster City, CA
- Full-service spatial transcriptomics, including sectioning, sample placement on two Xenium 5K slides, imaging, and data processing
- Support for data analysis and quality control via our bioinformatics team
Who Should Apply and What Project Types?
- This grant program is open only to U.S.- based applicants.
- Eligible applicants include:
- Academic researchers
- Biotech or pharmaceutical scientists
- Researchers studying human or mouse tissues
Projects should include:
- A clear biological hypothesis amenable to spatial transcriptomics (e.g., tumor microenvironment, tissue architecture, cellular heterogeneity, biomarker localization)
- A need for high-plex RNA profiling with single-cell spatial resolution, particularly for focused gene sets or pathway-level analyses
How to Apply
Submit a brief abstract describing:
- Research objective
- Rationale for using spatial transcriptomics / Xenium 5K
- Sample type (human/mouse, tissue type, FFPE or frozen) and number of samples
- Expected impact or significance of results
- If selected, when will your samples be ready for submission, or will they still need to be collected?
Submit your Abstract
Interested in other genomic or multiomic approaches?
Learn more about Signios Bio’s full range of certified genomics services and how we support research across diverse applications.
About Signios Biosciences
Signios Biosciences, (formerly named MedGenome US Research) is a multiomics and bioinformatics company dedicated to revealing the intricate signals within biological data. By combining cutting-edge AI, multiomic technologies, and scientific partnership, Signios Bio enables the discovery and development of next-generation therapies and diagnostics that are more inclusive, effective, and transformative.
About 10x Genomics
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more. Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology. To learn more, visit 10xgenomics.com and connect with us on X, Facebook, LinkedIn, Instagram, Bluesky and YouTube.
